The former head of the U.S. Centers for Disease Control and Prevention will soon head Merck & Co.'s $5 billion vaccines business.
Julie Gerberding, CDC director from 2002 until earlier this year, will take over as president of Merck's vaccines operations, overseeing sales of its existing vaccines, development of vaccines currently in the works, and continuation of plans to expand vacccinations in developing countries, Dow Jones Newswires reported.
She assumes her new position Jan. 25, replacing Margaret McGlynn, Merck's recently retired head of vaccines.
Richard Clark, Merck chairman and chief executive, described Gerberding as a "preeminent authority in public health, infectious diseases and vaccines," Dow Jones reported.